Two draft one-pagers for the Grove follow-up package, built on the standard Adaptyv slide chassis from real assay data. For internal review before anything goes to Grove.
Draft, not sent. Pricing on the first page is Julian's verbal call quote, marked draft and pending sign-off. The benchmark uses public Jain et al. 2017 antibody values. Neither slide is in a deck manifest yet, so nothing ships until approved.
01Developability assays and pricingthe panel, workflow, and cost split
Click to open full resolution in a new tab.
02Developability benchmarkapproved antibodies, each liability caught
